Evidence map›Paper›PMID 28181144›Full record

ReviewEndocrine2017

Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.

Giovanni Lombardi, Mosè Barbaro, Massimo Locatelli, Giuseppe Banfi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Endocrine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Giovanni LombardiIRCCS Istituto Ortopedico Galeazzi, Milano, Italy. giovanni.lombardi@grupposandonato.it.ORCID http://orcid.org/0000-0002-8365-985X
Mosè BarbaroLaboratory Medicine Service, San Raffaele Hospital, Milano, Italy.
Massimo LocatelliLaboratory Medicine Service, San Raffaele Hospital, Milano, Italy.
Giuseppe BanfiIRCCS Istituto Ortopedico Galeazzi, Milano, Italy.
Istituto Ortopedico Galeazzi · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endocrine function of bone is now a recognized feature of this tissue. Bone-derived hormones that modulate whole-body homeostasis, are being discovered as for the effects on bone of novel and classic hormones produced by other tissues become known. Often, however, the data regarding these last generation bone-derived or bone-targeting hormones do not give about a clear picture of their physiological roles or concentration ranges. A certain degree of uncertainty could stem from differences in the pre-analytical management of biological samples. The pre-analytical phase comprises a series of decisions and actions (i.e., choice of sample matrix, methods of collection, transportation, treatment and storage) preceding analysis. Errors arising in this phase will inevitably be carried over to the analytical phase where they can reduce the measurement accuracy, ultimately, leading discrepant results. While the pre-analytical phase is all important, in routine laboratory medicine, it is often not given due consideration in research and clinical trials. This is particularly true for novel molecules, such as the hormones regulating the endocrine function of bone. In this review we discuss the importance of the pre-analytical variables affecting the measurement of last generation bone-associated hormones and describe their, often debated and rarely clear physiological roles.

Indexed as

Pre-Analytical PhaseAdaptor Proteins, Signal TransducingAdiponectinBone and BonesBone Morphogenetic ProteinsFibroblast Growth Factor-23Fibroblast Growth FactorsGenetic MarkersHomeostasisHumansInterleukin-6Lipocalin-2Nicotinamide PhosphoribosyltransferaseOsteocalcinResistinAdaptor Proteins, Signal TransducingAdiponectinBone Morphogenetic ProteinsFibroblast Growth Factor-23Fibroblast Growth FactorsGenetic MarkersInterleukin-6Lipocalin-2Nicotinamide PhosphoribosyltransferaseOsteocalcinResistinSOST protein, humanBone metabolismHormonesLaboratory medicinePre-analytical phaseSample management

Identifiers

PMID28181144
OpenAlexW2586148393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.